WO1996032388A1 - Antheliatine, zahavine a et zahavine b a titre de nouveaux diterpenes de xenicane cytotoxiques - Google Patents
Antheliatine, zahavine a et zahavine b a titre de nouveaux diterpenes de xenicane cytotoxiques Download PDFInfo
- Publication number
- WO1996032388A1 WO1996032388A1 PCT/GB1996/000903 GB9600903W WO9632388A1 WO 1996032388 A1 WO1996032388 A1 WO 1996032388A1 GB 9600903 W GB9600903 W GB 9600903W WO 9632388 A1 WO9632388 A1 WO 9632388A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- zahavin
- antheliatin
- ppm
- xenicane
- glauca
- Prior art date
Links
- FPUYAAIJNARZMJ-FSLOEWCYSA-N [(1s,2r)-1-[(1r,4as,7e,9s,10s,11as)-1,9-diacetyloxy-10-hydroxy-7-methyl-11-methylidene-4a,5,6,9,10,11a-hexahydro-1h-cyclonona[c]pyran-4-yl]-1-acetyloxy-4-methylpent-3-en-2-yl] benzoate Chemical compound O([C@H](C=C(C)C)[C@@H](OC(C)=O)C=1[C@@H]2[C@@H](C([C@H](O)[C@@H](OC(C)=O)/C=C(C)/CC2)=C)[C@@H](OC(C)=O)OC=1)C(=O)C1=CC=CC=C1 FPUYAAIJNARZMJ-FSLOEWCYSA-N 0.000 title claims abstract description 31
- 229930189512 Zahavin Natural products 0.000 title description 3
- 231100000433 cytotoxic Toxicity 0.000 title description 3
- 230000001472 cytotoxic effect Effects 0.000 title description 3
- 229930004069 diterpene Natural products 0.000 title description 3
- 125000000567 diterpene group Chemical group 0.000 title description 3
- LPJHIUFOAPXTGH-XYOQDRHXSA-N [(1r,4as,7e,10r,11as)-4-(1,3-diacetyloxy-4-methylpent-4-enyl)-10-hydroxy-7-methyl-11-methylidene-4a,5,6,9,10,11a-hexahydro-1h-cyclonona[c]pyran-1-yl] acetate Chemical compound C=C([C@H](O)C/C=C(C)/CC1)[C@@H]2[C@H]1C(C(OC(C)=O)CC(OC(=O)C)C(C)=C)=CO[C@@H]2OC(C)=O LPJHIUFOAPXTGH-XYOQDRHXSA-N 0.000 claims abstract description 29
- YHVXAZWWUIIDJA-NMOJJFKUSA-N [(1r,4as,7e,11ar)-4-(1,3-diacetyloxy-4-methylpent-4-enyl)-7-methyl-11-methylidene-4a,5,6,9,10,11a-hexahydro-1h-cyclonona[c]pyran-1-yl] acetate Chemical compound C1C\C(C)=C\CCC(=C)[C@H]2[C@H]1C(C(OC(C)=O)CC(OC(=O)C)C(C)=C)=CO[C@@H]2OC(C)=O YHVXAZWWUIIDJA-NMOJJFKUSA-N 0.000 claims abstract description 27
- LPJHIUFOAPXTGH-UHFFFAOYSA-N Zahavin B Natural products C1CC(C)=CCC(O)C(=C)C2C1C(C(OC(C)=O)CC(OC(=O)C)C(C)=C)=COC2OC(C)=O LPJHIUFOAPXTGH-UHFFFAOYSA-N 0.000 claims abstract description 25
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- 241000329569 Anthelia glauca Species 0.000 claims abstract description 11
- 241000124009 Alcyonium Species 0.000 claims abstract description 10
- 241000124001 Alcyonacea Species 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 4
- 238000002955 isolation Methods 0.000 claims description 4
- 206010028980 Neoplasm Diseases 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 241000124008 Mammalia Species 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 150000004141 diterpene derivatives Chemical class 0.000 abstract description 2
- 241000894007 species Species 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000005100 correlation spectroscopy Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 238000003919 heteronuclear multiple bond coherence Methods 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 5
- 230000000259 anti-tumor effect Effects 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- 241000821031 Aquilegia aurea Species 0.000 description 4
- 101100400999 Caenorhabditis elegans mel-28 gene Proteins 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- JTACQGNVQPQYQN-UHFFFAOYSA-N Xenicin Natural products C1CC(C)=CC(OC(C)=O)CC(=C)C2C1C(C(OC(C)=O)C(OC(C)=O)C=C(C)C)=COC2OC(C)=O JTACQGNVQPQYQN-UHFFFAOYSA-N 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000003929 heteronuclear multiple quantum coherence Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 4
- 241001400178 Anthelia <soft coral> Species 0.000 description 3
- 235000014653 Carica parviflora Nutrition 0.000 description 3
- 241000243321 Cnidaria Species 0.000 description 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
- 241000006768 Xeniidae Species 0.000 description 3
- 125000002619 bicyclic group Chemical group 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 235000019439 ethyl acetate Nutrition 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000004264 monolayer culture Methods 0.000 description 3
- NORXPEYMDORBCO-UHFFFAOYSA-N 2,3,4,5,6,7,7a,8,9,10,11,11a-dodecahydrobenzo[b]oxonine Chemical compound O1CCCCCCC2CCCCC21 NORXPEYMDORBCO-UHFFFAOYSA-N 0.000 description 2
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 2
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 2
- 241000124003 Alcyoniidae Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 101150065749 Churc1 gene Proteins 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 102100038239 Protein Churchill Human genes 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000019011 Tasa Species 0.000 description 2
- 241000006770 Xenia Species 0.000 description 2
- ATPPXCUZTOKZDO-UHFFFAOYSA-N [Fe].C1(O)=C(O)C(=CC=C1)C(=O)N Chemical compound [Fe].C1(O)=C(O)C(=CC=C1)C(=O)N ATPPXCUZTOKZDO-UHFFFAOYSA-N 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- 230000003602 anti-herpes Effects 0.000 description 2
- 230000000118 anti-neoplastic effect Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- 201000005296 lung carcinoma Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 2
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- 239000007758 minimum essential medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940063673 spermidine Drugs 0.000 description 2
- 238000001551 total correlation spectroscopy Methods 0.000 description 2
- BVHUFJCFOXAURN-UHFFFAOYSA-N 13-Epi-9-desacetylxenicin Natural products C1CC(C)=CC(O)CC(=C)C2C1C(C(OC(C)=O)C(OC(C)=O)C=C(C)C)=COC2OC(C)=O BVHUFJCFOXAURN-UHFFFAOYSA-N 0.000 description 1
- SPJATKXUANCLPN-UHFFFAOYSA-N 2,3,4,4a,5,6,7,8,9,10,11,11a-dodecahydro-1h-benzo[9]annulene Chemical compound C1CCCCCCC2CCCCC21 SPJATKXUANCLPN-UHFFFAOYSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- XILIYVSXLSWUAI-UHFFFAOYSA-N 2-(diethylamino)ethyl n'-phenylcarbamimidothioate;dihydrobromide Chemical compound Br.Br.CCN(CC)CCSC(N)=NC1=CC=CC=C1 XILIYVSXLSWUAI-UHFFFAOYSA-N 0.000 description 1
- 238000012584 2D NMR experiment Methods 0.000 description 1
- 241000500635 Alcyonium digitatum Species 0.000 description 1
- 241000560536 Alcyonium palmatum Species 0.000 description 1
- 229930193977 Antheliolide Natural products 0.000 description 1
- QATHFSXCKTWEAB-UHFFFAOYSA-N Antheliolide A Natural products C12CCC(C)=CCCC(=C)C2C(OC2=O)C31CCC1C3C2=C(C)OC1(C)C QATHFSXCKTWEAB-UHFFFAOYSA-N 0.000 description 1
- VXAKHVQYDKQNTK-UHFFFAOYSA-N Antheliolide B Natural products CC1(C)OC(C)=C(C(OC2C34)=O)C5C1CCC52C3CCC(C)=CCCC14CO1 VXAKHVQYDKQNTK-UHFFFAOYSA-N 0.000 description 1
- 241000984343 Asplenium flaccidum Species 0.000 description 1
- 238000011765 DBA/2 mouse Methods 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000400611 Eucalyptus deanei Species 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 238000012565 NMR experiment Methods 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000243142 Porifera Species 0.000 description 1
- 241000251555 Tunicata Species 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- HGDULVKIUOELKF-UHFFFAOYSA-N Xenialactol Natural products C1CC(C)=CC(O)CC(=C)C2C(O)OCC(=CC=CC(C)(C)O)C21 HGDULVKIUOELKF-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002015 acyclic group Chemical group 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940125904 compound 1 Drugs 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000010997 low field NMR spectroscopy Methods 0.000 description 1
- 208000019420 lymphoid neoplasm Diseases 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940127073 nucleoside analogue Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002718 pyrimidine nucleoside Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229940115088 sea soft Drugs 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Definitions
- the present invention relates to new cytotoxic xenicane diterpenes.
- Anthelia belongs to the Xeniidae along with other Indo- Pacific genera of this family such as Cespituluria, Effatounaria, Heteroxemia and Xenia, all of which associate with symbiotic algae (zooxanthellae).
- Anthelia is characterized by having individual, non-retractile polyps united by a thin membrane and in this respect it differs from the related genera. Anthelia colonies tend to grow among other soft corals mainly of the Xeniidae family (Reference 14: Y. Benayahu, Proc. 5th Int.
- A. glauca (Lammarck, 1816) is the most common species of the genus and has a wide zoogeographical distribution throughout the Indo- Pacific region. On the coral reefs of Sodwana Bay, South Africa, A. glauca is sporadic in its abundance and appears on the reefs in small clusters of colonies at a depth range of 14-22 meters.
- a recent survey of the soft coral fauna of Sodwana Bay (Reference 12: Y. Benayahu, Invest. Rep. Oceanogr. Res. Inst. (Durban), No. 67, 1 (1993)) lists eight xeniid species. Unlike other reef areas such as the Red Sea (Reference 14), at Sodwana Bay, A. glauca is the most abundant xeniid.
- Alcyonium belongs to the family Alcyoniidae (Reference 15: J. Verseveldt and F.M. Bayer, Zool. Verhand Leiden, 245, 1 (1988)), and Alcyonium comprises species recorded within a large latitudinal range and found in various habitats along a wide depth gradient (Reference 16: J. Verseveldt, Zool. Med Leiden, 39, 153 (1964); Reference 17: J. Verseveldt, Amer. Mus. Nov., 2282, 1 (1967); Reference 18: J. Verseveldt, Zool. Verhand Leiden, 117, 1 (1971); Reference 19: J. Verseveldt, Zool.
- aurea is an azooxanthellated species collected at Sodwana Bay (Reference 13: Y Benayahu and M. Schleyer, in press). A. aurea was found at a depth of 28-36 meters, where almost no soft corals associated with endosymbiotic algae appear. There is no doubt that at Sodwana Bay A. aurea belongs to communities living below the euphotic zone.
- the present invention provides three new compounds extracted and isolated from soft corals.
- the compounds are antheliatin, zahavin A and zahavin B, the following formulae (I) and (II):
- the compounds of the present invention exhibit antitumor activity.
- the present compounds exhibit antitumour activity against cell lines derived from human tumors, such as P-388 mouse lymphoma, A-549 human lung carcinoma, HT-29 human colon carcinoma and MEL-28 human melanoma.
- the present invention also provides a method of treating a mammal affected by a malignant tumor sensitive to antheliatin, zahavin A, or zahavin B , which comprises administering a therapeutically effective amount of antheliatin, zahavin A, and zahavin B, or a pharmaceutical composition thereof.
- the present invention further provides pharmaceutical compositions which contain as active ingredient the compound antheliatin, zahavin A or zahavin B, as well as a process for their preparation.
- a further aspect of the invention is a method for preparing the compounds, which comprises extraction and isolation from the respective soft coral, Anthelia glauca for antheliatin or Alcyonium aurea for zahavin a and zahavin B.
- pharmaceutical compositions include any solid (tablets, pills, capsules, granules, etc.) or liquid (solutions, suspensions or emulsions) with suitable formulation for oral, topical or parenteral administration, and they may contain the pure compound or in combination with any carrier or other pharmacologically active compounds. These compositions may need to be sterile when administered parenterally.
- a pharmaceutical composition comprising antheliatin, zahavin A or zahavin B, will vary according to the pharmaceutical formulation, the mode of application, and the particular situs, host and tumor being treated. Other factors like age, body weight, sex, diet, time of administration, rate of excretion, condition of the host, drug combinations, reaction sensitivities and severity of the disease shall be taken into account. Administration can be carried out continuously or periodically within the maximum tolerated dose.
- the antitumor cells employed were P-388 (suspension culture of a lymphoid neoplasm from DBA/2 mouse), A-549 (monolayer culture of a human lung carcinoma), HT-29 (monolayer culture of a human colon carcinoma) and MEL-28 (monolayer culture of a human melanoma).
- P-388 cells were seeded into 16 mm wells at 1 x 10 cells per well in 1 ml aliquots of MEM 5FCS containing the indicated concentration of drug. A separate set of cultures without drug was seeded as control growth to ensure that cells remained in exponential phase of growth. All determinations were carried out in duplicate. After three days of incubation at 37°C, 10% CO in a 98% humid atmosphere, an approximate IC50 was determined by comparing the growth in wells with drug to the growth in wells control.
- HT-29 and MEL-28 cells were seeded into 16 mm wells at 2 x 10 4 cells per well in 1 ml aliquots of MEM 10FCS containing the indicated concentration of drug.
- a separate set of cultures without drug was seeded as control growth to ensure that cells remained in exponential phase of growth. All determinations were carried out in duplicate. After three days of incubation at 37°C, 10% CO2 in a 98% humid atmosphere, the wells were stained with 0.1% Crystal Violet. An approximate IC50 was determined by comparing the growth in wells with drug to the growth in wells in control.
- Antheliatin (1) The soft coral Anthelia glauca was collected in Sodwana Bay South Africa, in May 1994 by divers using scuba A voucher (TASA 293) is deposited in the Zoological Department at Tel Aviv University
- TASA 217 A voucher (TASA 217) is deposited in the Zoological Department at Tel Aviv University.
- the gum was chromatographed first over a Sephadex LH-20 column eluted with MeOH- CHCl 3 -hexane, 1; 1;2) and then several times over Si gel columns eluted with hexane- EtOAc (8:2) to afford 2 (30 mg); Rf 0.7 (EtOAc-hexane, 1.1), and 3 (5 mg) Rf 0.65.
- the Sodwana Bay A. glauca in contrast to the Red Sea species, was found to contain a single diterpenoid designated antheliatin (1), a crystalline material, m.p. 165°C (MeOH), [ ⁇ ] D + 3.5° (c, 1.2, CHC1 3 ), 0.2 % dry wt.
- the four additional carbon atoms were assigned to (a) a polarized double bond ( ⁇ 13c 138.2 ppm(d) and 113.4 p ⁇ m( ⁇ )), (b) a lactol-methine ( ⁇ 13c 91.9 ppm (d), ⁇ , 5.77 ppm(d)) and (c) an additional aliphatic methine ( ⁇ J3c 38.4 ppm (d)).
- the low-field nmr signal of the lactol-proton ( ⁇ 1H , 5.77 ppm) suggested that the third acetate was attached to this position (7).
- HMBC CH-Hetero correlations in the nmr spectrum of 1, between (a) and C-atom of the methine C-4a, ( ⁇ 13C 38.9 ppm), the allylic pair H-6 and 6' and protons H-5 and 5' of B, the other end-methine of moiety B (H-l la), and H-3, and (b) between C-4 ( ⁇ 13C 1 13.4 ppm), one of the polarized double bond carbon atoms, and protons H-5 and 5' of site B and H-12 of A ( ⁇ 1H 5.69 ppm), suggested C-4 and C-4a to be the link between moieties A and B, a connection which was further extended by correlations between C-12 and H-3.
- the location of this OH-group was suggested mainly on the basis of the following CH-correlations, deduced from an HMBC experiment: C-8/H-10; C- lO/H-19; C-1 la/H-19 as well as from homo-COSY correlations i.e. H-l 0/9,9' and H- 88/9,9'.
- the chemical shifts of C-9 and C-1 la also support the C'lO location of the OH-group; (If the OH group was on C-9 the line of C-10 should have been at ca.
- Zahavin B (3) is very unstable both under mild basic and mild acidic conditions; the compound decomposes readily under acetylation conditions (Ac 2 O, pyridine, CH 2 C1 2 ) or in a CDC1 3 solution.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU53389/96A AU5338996A (en) | 1995-04-13 | 1996-04-15 | Antheliatin, zahavin a and zahavin b: new cytotoxic xenicane diterpenes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9507908.3 | 1995-04-13 | ||
GBGB9507908.3A GB9507908D0 (en) | 1995-04-13 | 1995-04-13 | Antheliathin,zahavin A and zahavin B:new cytotoxic xenicane diterpenes |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996032388A1 true WO1996032388A1 (fr) | 1996-10-17 |
Family
ID=10773172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1996/000903 WO1996032388A1 (fr) | 1995-04-13 | 1996-04-15 | Antheliatine, zahavine a et zahavine b a titre de nouveaux diterpenes de xenicane cytotoxiques |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5338996A (fr) |
GB (1) | GB9507908D0 (fr) |
WO (1) | WO1996032388A1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100350891B1 (ko) * | 2000-03-08 | 2002-09-05 | 한국해양연구원 | 아칼리시제니올리드 c, d, e 및 f |
WO2011111804A1 (fr) * | 2010-03-11 | 2011-09-15 | 学校法人早稲田大学 | Composé antiprotozoaire provenant de coelentérés |
CN113402391A (zh) * | 2021-05-07 | 2021-09-17 | 宁波大学 | 波伦鳞花软珊瑚来源的二萜类化合物及其制备方法和用途 |
-
1995
- 1995-04-13 GB GBGB9507908.3A patent/GB9507908D0/en active Pending
-
1996
- 1996-04-15 AU AU53389/96A patent/AU5338996A/en not_active Abandoned
- 1996-04-15 WO PCT/GB1996/000903 patent/WO1996032388A1/fr active Application Filing
Non-Patent Citations (7)
Title |
---|
BOWDEN B F ET AL: "Studies of Australian soft corals. XXVIII. The structure determination of two new diterpenes from the genus Xenia (Alcyonacea)", AUST. J. CHEM. (AJCHAS,00049425);82; VOL.35 (5); PP.997-1002, JAMES COOK UNIV. NORTH QUEENSLAND;DEP. CHEM. BIOCHEM.; TOWNSVILLE; 4811; AUSTRALIA (AU), XP002006328 * |
BRAEKMAN J C ET AL: "Chemical studies of marine invertebrates. XXXIX. Three novel diterpenoids from the soft coral Xenia novae-britanniae", BULL. SOC. CHIM. BELG. (BSCBAG,00379646);79; VOL.88 (1-2); PP.71-7, UNIV. LIBRE BRUXELLES;FAC. SCI.; BRUSSELLS; B-1050; BELG., XP002006327 * |
COVAL S J ET AL: "Two new xenicin diterpenoids from the octocoral Anthelia edmondsoni", TETRAHEDRON (TETRAB,00404020);84; VOL.40 (19); PP.3823-8, UNIV. HAWAII;DEP. CHEM.; HONOLULU; 96822; HI; USA (US), XP002006326 * |
GREEN D ET AL: "Antheliolide A and B: two new C24-acetoacetylated diterpenoids of the soft coral Anthelia glauca", TETRAHEDRON LETT. (TELEAY,00404039);88; VOL.29 (13); PP.1605-8, TEL AVIV UNIV.;SCH. CHEM.; RAMAT AVIV; 69978; ISRAEL (IL), XP002006325 * |
OCHI M ET AL: "Acalycigorgins A, B, and C, three new biologically active diterpenoids from the gorgonian Acalycigorgia sp", HETEROCYCLES (HTCYAM,03855414);93; VOL.36 (1); PP.41-4, KOCHI UNIV.;FAC. SCI.; KOCHI; 780; JAPAN (JP), XP002006324 * |
OCHI M ET AL: "Biologically active xenicane diterpenoids from the gorgonian Acalycigorgia sp", HETEROCYCLES (HTCYAM,03855414);94; VOL.38 (1); PP.151-8, KOCHI UNIV.;FAC. SCI.; KOCHI; 780; JAPAN (JP), XP002006323 * |
RUDI A ET AL: "Antheliatin and zahavins A and B, three new cytotoxic xenicane diterpenes from two soft corals", J. NAT. PROD. (JNPRDF,01633864);95; VOL.58 (10); PP.1581-6, TEL AVIV UNIV.;SCH. CHEM.; TAL AVIV; 69978; ISRAEL (IL), XP002006322 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100350891B1 (ko) * | 2000-03-08 | 2002-09-05 | 한국해양연구원 | 아칼리시제니올리드 c, d, e 및 f |
WO2011111804A1 (fr) * | 2010-03-11 | 2011-09-15 | 学校法人早稲田大学 | Composé antiprotozoaire provenant de coelentérés |
CN102812015A (zh) * | 2010-03-11 | 2012-12-05 | 学校法人早稻田大学 | 来自腔肠动物的抗原虫化合物 |
EP2546245A1 (fr) * | 2010-03-11 | 2013-01-16 | Waseda University | Composé antiprotozoaire provenant de coelentérés |
EP2546245A4 (fr) * | 2010-03-11 | 2013-05-29 | Univ Waseda | Composé antiprotozoaire provenant de coelentérés |
US8722909B2 (en) | 2010-03-11 | 2014-05-13 | Waseda University | Antiprotozoal compound derived from coelenterata |
JP5721186B2 (ja) * | 2010-03-11 | 2015-05-20 | 学校法人早稲田大学 | 腔腸動物由来抗原虫化合物 |
CN113402391A (zh) * | 2021-05-07 | 2021-09-17 | 宁波大学 | 波伦鳞花软珊瑚来源的二萜类化合物及其制备方法和用途 |
CN113402391B (zh) * | 2021-05-07 | 2022-04-26 | 宁波大学 | 波伦鳞花软珊瑚来源的二萜类化合物及其制备方法和用途 |
Also Published As
Publication number | Publication date |
---|---|
AU5338996A (en) | 1996-10-30 |
GB9507908D0 (en) | 1995-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2626889B2 (ja) | ブリオスタチン類 | |
Sekine et al. | Structure and relative stereochemistry of a new polycyclic alkaloid, asparagamine A, showing anti-oxytocin activity, isolated from Asparagus racemosus | |
US6358957B1 (en) | Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds | |
GB2033398A (en) | L compositions containing them cyclosporin derivatives their production and pharmaceutica | |
CA1060003A (fr) | Les n-trifluoroacetyladriamycin-14-alcanoates et produits therapeutiques qui en contiennent | |
US5196447A (en) | Neristatin 1 | |
KOMIYAMA et al. | Structural study of a new antitumor antibiotic, kazusamycin | |
JPH0977791A (ja) | ペプチド誘導体及びその用途 | |
US5661175A (en) | Hemiasterlin and geodiamolide TA | |
Zeng et al. | Two new polycyclic aromatic alkaloids from the Okinawan marine sponge Biemna sp. | |
Chu et al. | A new potent antifungal agent from Actinoplanes sp | |
WO1996032388A1 (fr) | Antheliatine, zahavine a et zahavine b a titre de nouveaux diterpenes de xenicane cytotoxiques | |
EP0687673A1 (fr) | Dérivés d'oxazole comme agents anti-tumoraux | |
EP0647625A1 (fr) | Delaminomycines, antibiotiques nouveaux presentant une activite immunosuppressive, et leur production | |
US7439265B2 (en) | Irciniastatins a and b | |
US4895852A (en) | Antitumor alkaloids | |
US6476065B2 (en) | Discalamide compounds and their use as anti-proliferative agents | |
US5514708A (en) | Cytotoxic metabolites from Myriapora truncata | |
KR100533244B1 (ko) | 스폰지로부터 분리한 아스마린 a 및 b를 포함하는 세포독성 알칼로이드 유도체 | |
WO1997010242A1 (fr) | Trois nouveaux macrolides cytotoxiques extraits d'une eponge marine | |
Itoh et al. | Isolation of two unusual tetrahydroisoquinoline-monoterpene glucosides from Alangium lamarckii as possible intermediates in the non-enzymatic formation of alangimarine from alangiside | |
US6420357B1 (en) | Cytotoxic alkaloid derivatives including Asmarine A and B isolated from a sponge | |
US4912133A (en) | BU-3862T antitumor antibiotic | |
US3095418A (en) | 3-[2-(5-acetoxy-2-hydroxy-3, 5-dimethylcyclohexyl)-2-hydroxyethyl] glutarimide and derivatives thereof | |
US20040127540A1 (en) | Antibiotic Cyan426-A |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |